* Overview
CNS Spectrums, a monthly Index Medicus/MEDLINE journal designed to bridge the clinical information needs of 48,000 psychiatrists and neurologists, will publish 12 issues in 2010. Introduced in 1996, CNS Spectrums reaches more physicians than any other peer-reviewed neuroscience journal in the U.S. In addition, the 2007 ISI Journal Citation Reports’ Impact Factor for CNS Spectrums is 2.746 for Clinical Neurology and 3.409 for Psychiatry. The Impact Factor is based on a total of 1,179 citations. This ranking places CNS Spectrums in the top half of all Psychiatry and Neurology journals included in the study.
* Suggested Peer Reviewers (Required) Authors must provide at least four (4) names of qualified potential reviewers with no conflict of interest in reviewing the work. Contact information with affiliations and e-mail addresses should be included. Peer reviews are anonymous.
* Article Submission If you would like to submit an article to CNS Spectrums, please review all of the guidelines listed below and click the “Article Submission” button at the bottom of this page.
Scope of Manuscripts
CNS Spectrums will consider and encourages the following types of articles for publication:
1. Original Research presents methodologically sound, new original study data that is in the following format: objective, methods, results, discussion, and conclusion.
2. Review articles that are comprehensive articles, which summarize and synthesize the literature on various neuropsychiatric topics and presented in a scholarly and clinically relevant fashion. Diagnostic and treatment algorithms should be designed to aid the clinician in diagnosis and treatment.
3. Scholarly Case-Based Reviews that are no longer than 3,500 words.
4. Letters to the Editor will be considered and are encouraged for publication. Letters should be submitted via the ScholarOne/CNS Spectrums website (please see below). All letters will be edited for style, clarity, and length.
Manuscript Submissions
Format: When formatting your manuscript, please refer to the AMA template, which can be found
here.
CNS Spectrums has implemented the ScholarOne Manuscripts program to manage all future submissions. ScholarOne Manuscripts (formerly known as Manuscript Central) is a web-based submission, peer review, and editing program. This system will help to develop a more streamlined and efficient process for tracking peer review data and manuscripts. Manuscripts must be submitted through the ScholarOne website.
For more information about the ScholarOne program, please contact Lisa Arrington, Senior Acquisitions Editor,
CNS Spectrums, either via e-mail at
lla@mblcommunications.com or via phone at 212-328-0800, x220.
If possible, manuscripts should be provided in MS Word (saving the file in a lower version, eg, MS Word 3.0, is also encouraged.) Diagrams, tables, slides and figures should be provided in PhotoShop, Adobe Illustrator, PowerPoint, MS Word, or JPEG formats.
Letters of Permission to Reproduce Previously Published Material All material reproduced from previously published copyrighted material must be accompanied by a letter of permission from the copyright holder. All such material should include a full credit line (eg, in the figure or table legend) acknowledging the original source. Any citation of unpublished material or personal communication should also be accompanied by a letter of permission for anyone who is not an author of the paper.
Manuscript Preparation
Length: Reviews and Original Research articles should not exceed 7,500 words (excluding the Reference List). Letters to the Editor should not exceed 750 words (excluding the Reference List). Scholarly Case-Based reviews should not exceed 3,500 words.
Please note: If your article is Original Research, it should be formatted as follows: Abstract (100–200 words); Introduction, Methods; Results; Discussion; Conclusion; References (numbered and comprehensive list).
Spacing and Pagination: Manuscripts should be double-spaced and numbered.
Abstract: Authors must provide an abstract of 100-200 words; a paragraph that serves as a summary of the entire paper; outlining the main ideas for the reader. For an original research data article, please format it with the following sections: 1) Objective/Introduction 2) Methods; 3) Results; 4) Discussion; and 5) Conclusion.
Focus Points: Please provide 3 focus points that begin with an action verb and specify what the reader should know after reading the article.
Introduction: Authors must provide an introduction of 200-400 words The introduction should as a starting point, the introduction should set up the information to be discussed (background, history, key introductory facts, etc.).
Conclusion: (100-350 words) summarizes the main points of the manuscript. Please avoid using unqualified statements that are not completely supported by your data.
Figures/Tables: Please provide at least 2 original figures and/or tables.
References: Please use American Medical Association style. References should be superscripted in text, then numbered, and comprehensive in list. For example:
1. Goodkin K, Antoni MH, Helder L, et al. Psychoneuroimmunological aspects of disease progression among women and human papillomavirus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection. Int J Psychiatry Med. 1993;23(2):119-148.
* Please note: Regarding all journal references, please include both the volume numbers and issue numbers.
2. Stryer L. Biochemistry. 2nd ed. San Francisco, Calif: WH Freeman Co; 1980:559-596.
3. Alzheimer’s Disease Cooperative Study. Valproate protocal. Available at: http://adcs.ucsd.edu/VP_Protocol.htm. Accessed October 15, 2003.
Copyright: Materials are accepted for exclusive publication in CNS Spectrums and become the property of CNS Spectrums. Permission to reproduce material must be obtained from the publisher.
Reprints: MBL Communications offers reprints of all articles published in CNS Spectrums. If you would like to obtain a quote for reprints, please click here.
Permissions: If you would like to obtain permission to re-use material previously published in CNS Spectrums, please click here.
Disclosure of Commercial and Non-commercial Interests
Authors must include a statement about all forms of support, including grant and pharmaceutical support, affiliations, and honoraria received for past and present material from the previous 12 months. Such information may, at the editor’s discretion, be shared with reviewers.
Off-label Usage
Authors must disclose any unlabeled, unapproved, experimental, and/or investigational usages of drugs mentioned in the article and include the condition for which these drugs are being used off-label. Below is an example of the standardized format:
This article includes discussion of the following unapproved/experimental medications for adult ADHD: buproprion, clonidine, guanficine, modafinil, and venlafaxine.
Submission Checklist:
• Original manuscript, with cover letter
• Copies of permission letters to reproduce previously published and unpublished material, including tables and/or figures.
• An abstract for the article (100-200 words).
• An introduction for the article (200-400 words).
• A separate conclusion must be included.
• Three focus points that dictate the main focus of the manuscript in bulleted format.
• Names and affiliations of at least 4 potential peer reviewers.